As 2024 is nearing its end, investors with a time machine are looking to visit December 2023 and take their long positions in ...
The Russian mRNA vaccine under development can be “personalised” based on the genetic analysis of each person’s tumour to ...
With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback